News

FDA approves alirocumab, first injectable lipid-lowering biologic therapy

Publish date: July 24, 2015

 

FROM THE FDA

References

The prescribing information is available at http://1.usa.gov/1KpIU82.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

Cognitive impairment signals subclinical vascular disease
MDedge Family Medicine
WCD: Psoriasis plus depression magnifies MI risk
MDedge Family Medicine
ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dots
MDedge Family Medicine
EULAR: Panel previews updated CVD recommendations
MDedge Family Medicine
Half of Hispanics unaware of their high cholesterol
MDedge Family Medicine
Rosacea linked to dyslipidemia, hypertension, CAD
MDedge Family Medicine
Study quantifies risks linked to cardiac multimorbidity
MDedge Family Medicine
FDA will strengthen heart attack, stroke risk warnings for all NSAIDs
MDedge Family Medicine
Cardiovascular disease prevention should start in childhood
MDedge Family Medicine
ACC/AHA cholesterol guideline found efficient, cost effective
MDedge Family Medicine

Related Articles